(Q37818890)

English

Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion

scientific article published on 08 December 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

prion protein family

0 references

Yraima Cordeiro

0 references

1

0 references

author name string

Tuane C R G Vieira

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Mariana P B Gomes

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Luciana P Rangel

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sandra M N Scapin

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

publication date

8 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

306-317

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Prions: protein aggregation and infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Further purification and characterization of scrapie prions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Self-replication and scrapie

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Intriguing nucleic-acid-binding features of mammalian prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Formation of native prions from minimal components in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Physiology of the prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Mice devoid of PrP are resistant to scrapie

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

A cellular gene encodes scrapie PrP 27-30 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Copper binding to the prion protein: structural implications of four identical cooperative binding sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

PrP interactions with nucleic acids and glycosaminoglycans in function and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Scrapie-associated PrP accumulation and its inhibition: revisiting the amyloid-glycosaminoglycan connection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

NMR solution structure of the human prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

X-ray diffraction of scrapie prion rods and PrP peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Generating a prion with bacterially expressed recombinant prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

RNA molecules stimulate prion protein conversion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Polymerization of murine recombinant prion protein in nucleic acid solution

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Hydration and packing effects on prion folding and beta-sheet conversion. High pressure spectroscopy and pressure perturbation calorimetry studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Scrapie strain variation and mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Strain-dependent differences in beta-sheet conformations of abnormal prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Eight prion strains have PrP(Sc) molecules with different conformations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Darwinian evolution of prions in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Cytosolic prion protein in neurons.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

A transmembrane form of the prion protein in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Combinatorial Control of Prion Protein Biogenesis by the Signal Sequence and Transmembrane Domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Interactions of prion protein with intracellular proteins: so many partners and no consequences?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Normal prion protein has an activity like that of superoxide dismutase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Interaction of prion peptide HuPrP106-126 with nucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

A 'unified theory' of prion propagation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Structural insights into the interaction between prion protein and nucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Enhanced prion protein stability coupled to DNA recognition and milieu acidification

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The peculiar interaction between mammalian prion protein and RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Structural determinants of conformationally selective, prion-binding aptamers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Characterization and application of a novel RNA aptamer against the mouse prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Phosphorothioate oligonucleotides reduce PrP levels and prion infectivity in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The role of structural disorder in the function of RNA and protein chaperones

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

DISPLAR: an accurate method for predicting DNA-binding sites on protein surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Protein microarray analysis identifies human cellular prion protein interactors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Non-coding RNAs: new players in eukaryotic biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

A large ribonucleoprotein particle induced by cytoplasmic PrP shares striking similarities with the chromatoid body, an RNA granule predicted to function in posttranscriptional gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Matrix proteoglycans: from molecular design to cellular function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Sulfated glycosaminoglycans in amyloid plaques of prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Cell-surface prion protein interacts with glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Cellular heparan sulfate participates in the metabolism of prions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Amyloidogenic properties of the prion protein fragment PrP(185-208): comparison with Alzheimer's peptide Abeta(1-28), influence of heparin and cell toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Heparin Binding by Murine Recombinant Prion Protein Leads to Transient Aggregation and Formation of RNA-Resistant Species

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Copper-dependent co-internalization of the prion protein and glypican-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Identification of prion protein binding proteins by combined use of far-Western immunoblotting, two dimensional gel electrophoresis and mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Identification of proteins with high affinity for refolded and native PrPC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Immunoaffinity reactors for prion protein qualitative analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The comprehensive native interactome of a fully functional tagged prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Evolutionary descent of prion genes from the ZIP family of metal ion transporters

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Involvement of cytoplasmic factors regulating the membrane orientation of P-glycoprotein sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Pathogenic mutations in the glycosylphosphatidylinositol signal peptide of PrP modulate its topology in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Prion protein biosynthesis and its emerging role in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Transmissible and genetic prion diseases share a common pathway of neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Biosynthesis of prion protein nucleocytoplasmic isoforms by alternative initiation of translation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The highways and byways of prion protein trafficking

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Functionally different GPI proteins are organized in different domains on the neuronal surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The GPI-anchor and protein sorting

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Identification of the heparan sulfate binding sites in the cellular prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Mechanism of the metal-mediated endocytosis of the prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Trafficking of prion proteins through a caveolae-mediated endosomal pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Clathrin-independent internalization of normal cellular prion protein in neuroblastoma cells is associated with the Arf6 pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Endocytic Intermediates Involved with the Intracellular Trafficking of a Fluorescent Cellular Prion Protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Cryo-immunogold electron microscopy for prions: toward identification of a conversion site

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Identification of an intracellular site of prion conversion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Molecular basis of scrapie strain glycoform variation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Distinct molecular phenotypes in bovine prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Accelerated high fidelity prion amplification within and across prion species barriers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Transmission barriers for bovine, ovine, and human prions in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

A new variant of Creutzfeldt-Jakob disease in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

In vitro studies of the transmission barrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

NMR structure of the mouse prion protein domain PrP(121-231)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Three-dimensional structures of prion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

A structural overview of the vertebrate prion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Prion protein NMR structure and species barrier for prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

De novo generation of infectious prions in vitro produces a new disease phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

NMR structure of the bovine prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Unique Structural Characteristics of the Rabbit Prion Protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Prion protein misfolding and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Analysis of PrP conformation using circular dichroism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Structural differences between TSEs strains investigated by FT-IR spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

From conversion to aggregation: protofibril formation of the prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Evidence for assembly of prions with left-handed beta-helices into trimers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Molecular structure of amyloid fibrils: insights from solid-state NMR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Recombinant prion protein induces a new transmissible prion disease in wild-type animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

A protease-resistant protein is a structural component of the scrapie prion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Prion strain discrimination using luminescent conjugated polymers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Mammalian prion biology: one century of evolving concepts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Quinacrine-induced cytolytic hepatitis in sporadic Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Synthesis of monomeric and dimeric acridine compounds as potential therapeutics in Alzheimer and prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Synthesis and anti-prion activity evaluation of aminoquinoline analogues

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

The inhibition of prions through blocking prion conversion by permanently charged branched polyamines of low cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Antiprion immunotherapy: to suppress or to stimulate?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Antibody to DNA detects scrapie but not normal prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4'-dianilino-1,1'-binaphthyl-5,5'-sulfonate (bis-ANS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Efficient and specific down-regulation of prion protein expression by RNAi

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Suppression of prion protein in livestock by RNA interference.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Structure of the Flexible Amino-Terminal Domain of Prion Protein Bound to a Sulfated Glycan

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Reciprocal remodeling upon binding of the prion protein to its signaling partner hop/STI1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

Spontaneous generation of mammalian prions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.12.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMETH.2010.12.002

1 reference

https://api.fatcat.wiki/v0/release/byii3yuxy5dmvlbcgcm77sp63y

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_byii3yuxy5dmvlbcgcm77sp63y

1 reference

https://api.fatcat.wiki/v0/release/byii3yuxy5dmvlbcgcm77sp63y

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/byii3yuxy5dmvlbcgcm77sp63y

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37818890&oldid=2216353714"